-
Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey
Astrid Chevance, Philippe Ravaud, Anneka Tomlinson, Catherine Le Berre, Birgit Teufer, Suzanne Touboul, +4 more
204citations -
Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices2021 Neuroscience & Biobehavioral Reviews review Medicine Treatment of Major Depression Open access cited by 1 patent
Lucas Remoaldo Trambaiolli, Simon H. Kohl, David E.J. Linden, David M. A. Mehler
73citations -
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Joost J. Breeksema, Alistair R. Niemeijer, Bouwe Kuin, Jolien K. E. Veraart, Eric H. G. J. M. Vermetten, Jeanine Kamphuis, +2 more
28citations -
Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers
Francis M. Dijkstra, Patricio O’Donnell, Erica Surya Klaassen, Derek L. Buhl, Mahnaz Asgharnejad, Laura B. Rosen, +3 more
24citations -
Prevalence and prediction of dropout during depression treatment in routine outpatient care: an observational study2022 European Archives of Psychiatry and Clinical Neuroscience article Medicine Treatment of Major Depression Open access
Dyllis Aimée van Dijk, Mathijs L. Deen, Th. Michael van den Boogaard, Henricus Gerardus Ruhé, Jan Spijker, Frenk P. M. L. Peeters
14citations -
Hippocampal, thalamic, and amygdala subfield morphology in major depressive disorder: an ultra-high resolution MRI study at 7-Tesla2024 European Archives of Psychiatry and Clinical Neuroscience article Medicine Treatment of Major Depression Open access
Weijian Liu, Jurjen Heij, Shu Qing Liu, Luka C. Liebrand, Matthan W.A. Caan, Wietske van der Zwaag, +4 more
13citations -
Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder2022 The World Journal of Biological Psychiatry article Medicine Treatment of Major Depression Open access
Matti Gärtner, Mischa de Rover, Lena Václavů, Milan Scheidegger, Matthias J.P. van Osch, Simone Grimm
11citations -
Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis2021 Trends in Psychiatry and Psychotherapy review Medicine Treatment of Major Depression Open access
Mohamed Elsayed, Khaled Ashraf Mohamed, Khaled Tarek Dardeer, Dalia K. Zaafar, Soha Osama Hassanin, Ramy Abdelnaby, +1 more
10citations